Finance

Lists
Why is 538965 down 3,61%?
Dive Deeper
538965:BOM
Concord Drugs Ltd
69,10 INR
-3,61%
(-2,59) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 538965...
Open
73,97 INR
High
73,97 INR
Low
66,30 INR
Mkt. cap
910,39 მლნ.
Avg. vol.
4,48 ათ.
Volume
4,88 ათ.
P/E ratio
30,84
52-wk high
92,52 INR
52-wk low
61,00 INR
EPS
2,24 INR
Shares outstanding
7,86 მლნ.
No. of employees
250
Open
73,97 INR
High
73,97 INR
Low
66,30 INR
Mkt. cap
910,39 მლნ.
Avg. vol.
4,48 ათ.
Volume
4,88 ათ.
P/E ratio
30,84
52-wk high
92,52 INR
52-wk low
61,00 INR
EPS
2,24 INR
Shares outstanding
7,86 მლნ.
No. of employees
250
News stories
From web sources and news partners
About Concord Drugs Ltd
CEO-
Employees250
Founded1995
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
102,76 მლნ.
169,66 მლნ.
378,88 მლნ.
209,39 მლნ.
Cost of goods sold
77,18 მლნ.
143,91 მლნ.
344,01 მლნ.
169,14 მლნ.
Cost of revenue
77,18 მლნ.
143,91 მლნ.
344,01 მლნ.
169,14 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,95 მლნ.
12,37 მლნ.
17,53 მლნ.
12,56 მლნ.
Operating expense
18,01 მლნ.
19,60 მლნ.
23,55 მლნ.
20,92 მლნ.
Total operating expenses
95,19 მლნ.
163,52 მლნ.
367,56 მლნ.
190,06 მლნ.
Operating income
7,57 მლნ.
6,15 მლნ.
11,32 მლნ.
19,33 მლნ.
Other non operating income
26,00 ათ.
211,00 ათ.
-1,14 მლნ.
82,00 ათ.
EBT including unusual items
2,71 მლნ.
2,96 მლნ.
7,48 მლნ.
15,45 მლნ.
EBT excluding unusual items
2,71 მლნ.
2,96 მლნ.
7,48 მლნ.
15,45 მლნ.
Income tax expense
789,00 ათ.
792,00 ათ.
2,20 მლნ.
4,31 მლნ.
Effective tax rate
29,08%
26,75%
29,36%
27,89%
Other operating expenses
3,67 მლნ.
4,16 მლნ.
2,50 მლნ.
4,87 მლნ.
Net income
1,92 მლნ.
2,17 მლნ.
5,28 მლნ.
11,14 მლნ.
Net profit margin
1,87%
1,28%
1,39%
5,32%
Earnings per share
-
-
-
-
Interest and investment income
-
-
334,00 ათ.
-
Interest expense
-4,88 მლნ.
-3,40 მლნ.
-3,04 მლნ.
-3,96 მლნ.
Net interest expenses
-4,88 მლნ.
-3,40 მლნ.
-2,71 მლნ.
-3,96 მლნ.
Depreciation and amortization charges
3,39 მლნ.
3,07 მლნ.
3,53 მლნ.
3,49 მლნ.
EBITDA
11,10 მლნ.
9,72 მლნ.
14,74 მლნ.
22,74 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები